Imprimis, SightLife Surgical enter sales and marketing agreement for Serum Tears

Imprimis Pharmaceuticals and SightLife Surgical have signed a strategic sales and marketing agreement for Imprimis’ Serum Tears for chronic dry eye, according to a press release.SightLife’s sales team will offer Serum Tears to physicians, large practice groups, surgery centers, hospitals and health care organizations under the agreement, the release said.